WASHINGTON — A new bill from Sen. Elizabeth Warren (D-Mass.) proposes a novel solution to the problem of high drug prices: bringing the U.S. government into the drug manufacturing business.

Warren plans to introduce a new bill, the Affordable Drug Manufacturing Act, Tuesday with Rep. Jan Schakowsky (D-Ill.) that would mandate the creation of an Office of Drug Manufacturing, which would be tasked with ensuring generic drugs are available to consumers at accessible prices. Among the potential tools at the office’s disposal: making the drugs itself.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

    • I had the same experience with my not being able to open the STATNewsletters, a few times.

      The only way to get your ability to have the newsletters open is to go in and sign in again, using your email address and the password that you created for the STATnewletters.

      Then you will have to sign up again, for the several newsletters that you wanted and if you were interested in reading more of the STATPlus newsletters, add those to the list as you have to do with the ones that you already have done.

      It takes a few minutes, yet I am grateful to be able to do it again. It should definitely work after you must re-enter your information again.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy